trodelvy
gilead sciences ireland uc - sacituzumab govitecan - breast neoplasms; triple negative breast neoplasms - Æxlishemjandi lyf - trodelvy as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic triple-negative breast cancer (mtnbc) who have received two or more prior systemic therapies, including at least one of them for advanced disease.
minirin frostþurrkuð tafla 60 míkróg
ferring lægemidler a/s - desmopressinum acetat - frostþurrkuð tafla - 60 míkróg
minirin frostþurrkuð tafla 240 míkróg
ferring lægemidler a/s - desmopressinum acetat - frostþurrkuð tafla - 240 míkróg
minirin frostþurrkuð tafla 120 míkróg
ferring lægemidler a/s - desmopressinum acetat - frostþurrkuð tafla - 120 míkróg
simdax innrennslisþykkni, lausn 2,5 mg/ml
orion corporation - levosimendanum inn - innrennslisþykkni, lausn - 2,5 mg/ml
nocdurna frostþurrkuð tafla 25 míkróg
ferring lægemidler a/s - desmopressinum acetat - frostþurrkuð tafla - 25 míkróg
nocdurna frostþurrkuð tafla 50 míkróg
ferring lægemidler a/s - desmopressinum acetat - frostþurrkuð tafla - 50 míkróg